Clinical Trial Update: A Study of Tris-Hydroxymethyl Aminomethane (THAM) Versus Sodium Bicarbonate in Cardiac Surgical Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial at Mayo Clinic is evaluating Tris-Hydroxymethyl Aminomethane (THAM) versus sodium bicarbonate for metabolic acidosis in cardiac surgery…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Acidosis

Drugs mentioned

• Sodium Bicarbonate (sodium bicarbonate)
• Tris-Hydroxymethyl Aminomethane (THAM)

Snippet

Sponsor: Mayo Clinic | Conditions: Metabolic Acidosis | Phase 4 | Status: NOT_YET_RECRUITING